Role of Notch 1 in Immune Tolerance
Role of Notch 1 in Immune Tolerance
批准号:
6782125
负责人:
JEFFREY A BLUESTONE
金额:
$22.73万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2006-03-31
关键词:
CD28 moleculeNOD mouseSCID mouseT cell receptorbiological signal transductioncellular immunitychimeric proteinsdendritic cellsdiabetes mellitusgenetic transcriptiongenetically modified animalsimmune tolerance /unresponsivenessimmunologic receptorslaboratory mouseleukocyte activation /transformationpancreatic islet transplantationtransfection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Recent advances in the understanding of T-cell activation have led to new therapeutic approaches in the treatment of immunological disorders. One attractive target of intervention has been the blockade of T cell-mediated co-stimulatory pathways, which result in more selective effects on only those T-cells that have encountered specific antigen. In fact, in some instances, CD28/B7 co-stimulatory pathway antagonists can induce antigen-specific tolerance that prevents the progression of autoimmune diseases and organ graft rejection. However, many other cell surface molecules exist on naive T cells that may play an important role in initiating immunity from the quiescent state. Moreover, it is clear that quiescent T cells can also function as regulatory T cells to promote immune tolerance by an as yet unknown mechanism suggesting that some of the cell surface proteins may provide functional activities beyond just determining whether cells effectively go into cell cycle. Notch, Serrate, and Delta are type 1 integral membrane proteins involved in cell-cell signaling crucial to normal cellular differentiation and in organogenesis. In the immune system, Notch signaling is critical for normal T cell development. Recently, a role for Notch signaling in mature T cells has been proposed based on the observation that engagement of Notch by Serrate could induce a profound state of unresponsiveness in peripheral T cells in vivo. Most interesting was the observation that these "unresponsive" T cells possessed regulatory abilities that on several levels appear similar to the CD25+ regulatory cells that are able to regulate autoimmunity. Our preliminary studies suggest that Notch-1 is an important regulator of T cell signaling in resting T cells and may be involved in tolerance. We hypothesize that Notch-1 plays a critical role in the intrinsic regulation of T cell responses by influencing the primary signaling pathways critical for activating naive T cells. This results in T cell inactivation or altered differentiation. Moreover, we hypothesize that manipulation of immune responses through Notch-1 can be used to alter autoimmunity and transplantation tolerance. In this application we propose to explore the mechanisms of Notch signaling in T cells and its application as follows: Specific Aim #1. To Identify the biochemical, cellular and genetic effects of Notch signaling in T cells; and Specific Aim #2. In vivo application of Notch signaling for the establishment of peripheral T cell tolerance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Designer Tregs for restoring tolerance in patients with type 1 diabetes
-
批准号:9459191
-
项目类别:
-
资助金额:$335.17万
-
财政年份:2017
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Project 2 - Specificity and repertoire of Tregs in T1D
-
批准号:9151389
-
项目类别:
-
资助金额:$40.87万
-
财政年份:2016
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation
-
批准号:8672260
-
项目类别:
-
资助金额:$98.32万
-
财政年份:2014
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Role of Innate Lymphoid Cells in Autoimmunity
-
批准号:8637675
-
项目类别:
-
资助金额:$23.61万
-
财政年份:2013
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"
-
批准号:8728396
-
项目类别:
-
资助金额:$5.72万
-
财政年份:2012
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"
-
批准号:8264452
-
项目类别:
-
资助金额:$24.64万
-
财政年份:2012
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Spontaneous Autoimmune Model of Peripheral Neuropathy
-
批准号:8116742
-
项目类别:
-
资助金额:$4.24万
-
财政年份:2010
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Expanding beta-cell mass"
-
批准号:7994038
-
项目类别:
-
资助金额:$118.56万
-
财政年份:2010
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Expanding beta-cell mass"
-
批准号:8322756
-
项目类别:
-
资助金额:$130.15万
-
财政年份:2010
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Expanding beta-cell mass"
-
批准号:8143503
-
项目类别:
-
资助金额:$130.15万
-
财政年份:2010
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Genetically Engineered Antigen Specific Treg to Treat Autoimmunity
-
批准号:7688822
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2009
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Islet Core
-
批准号:7510118
-
项目类别:
-
资助金额:$20.97万
-
财政年份:2007
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
CTLA-4 functions in tolerance and autoimmunity
-
批准号:7215474
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2006
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Flow Cytometry
-
批准号:7215480
-
项目类别:
-
资助金额:$24.05万
-
财政年份:2006
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Role of Notch 1 in Immune Tolerance
-
批准号:6876102
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2004
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Islet Metabolism Core
-
批准号:7925411
-
项目类别:
-
资助金额:$21.26万
-
财政年份:2003
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Diabetes Research and Training Center
-
批准号:6584737
-
项目类别:
-
资助金额:$117.83万
-
财政年份:2003
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
PILOT AND FEASIBILITY PROGRAM
-
批准号:6612298
-
项目类别:
-
资助金额:$7.57万
-
财政年份:2002
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
CORE--ISLET PRODUCTION
-
批准号:6612293
-
项目类别:
-
资助金额:$22.25万
-
财政年份:2002
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
CORE--MOUSE GENETICS
-
批准号:6612294
-
项目类别:
-
资助金额:$23.84万
-
财政年份:2002
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
海外基金